Cas:192057-12-8 TsDACH RuCl(p-cyMene) manufacturer & supplier

Chemical Name:TsDACH RuCl(p-cyMene)

CAS.NO:192057-12-8

Synonyms:TsDACH RuCl(p-cyMene)

Molecular Formula:C₂₃H₃₃ClN₂O₂RuS

Molecular Weight:N/A

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like TsDACH RuCl(p-cyMene) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TsDACH RuCl(p-cyMene) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,TsDACH RuCl(p-cyMene) Use and application,TsDACH RuCl(p-cyMene) technical grade,usp/ep/jp grade.

Related News: It is frequently associated with the presence of blasts or leukemic cells in the marrow. TsDACH RuCl(p-cyMene) manufacturer Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production. TsDACH RuCl(p-cyMene) supplier Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production. TsDACH RuCl(p-cyMene) vendor Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration. TsDACH RuCl(p-cyMene) factory Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.